Home / Questions / Economic Value Added Suwon Pharmaceuticals invests heavily in research and development (R...

Economic Value Added Suwon Pharmaceuticals invests heavily in research and development (R&D), although it must currently treat its R&D expenditures as expenses for financial accounting purposes

Economic Value Added

Suwon Pharmaceuticals invests heavily in research and development (R&D), although it must currently treat its R&D expenditures as expenses for financial accounting purposes. To encourage investment in R&D, Suwon evaluates its division managers using EVA. The company adjusts accounting income for R&D expenditures by assuming these expenditures create assets with a two year life. That is, the R&D expenditures are capitalized and then amortized over two years.

BK division of Suwon shows after-tax income of $2.5 million for year 2. R&D expenditures in year 1 amounted to $1 million and in year 2, R&D expenditures were $1.6 million. For purposes of computing EVA, Suwon assumes all R&D expenditures are made at the beginning of the year. Before adjusting for R&D, BK division shows assets of $10 million at the beginning of year 2 and current liabilities of $200,000. Suwon computes EVA using divisional investment at the beginning of the year and a 12 percent cost of capital.

Required

Compute EVA for BK division for year 2.

Jun 19 2020 Read more Less More

Answer (Solved)

question Subscribe To Get Solution

Recent Questions

Chat Now

Welcome to Live Chat

Welcome to MyCourseHelp Services, World's leading Academic solutions provider with Millions of Happy Students.

Please fill in the form